Jimin Shi Selected Research

Jimin Shi Research Topics

Disease

19	Leukemia 10/2023 - 05/2011
18	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 04/2011
15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 01/2016
10	Neoplasms (Cancer) 12/2023 - 04/2014
6	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 12/2012
6	Infections 01/2023 - 07/2013
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 01/2014
5	Residual Neoplasm 01/2023 - 06/2014
5	Multiple Myeloma 01/2023 - 12/2009
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2017 - 05/2009
4	Bronchiolitis Obliterans Syndrome 02/2024 - 03/2017
3	Lymphoma (Lymphomas) 01/2023 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 04/2014
3	Cytopenia 01/2023 - 01/2021
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2024 - 01/2023
2	Sleep Deprivation 12/2023 - 10/2020
2	Cytokine Release Syndrome 01/2023 - 01/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 07/2013
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022 - 06/2014
2	Pain (Aches) 01/2022 - 01/2017
2	Pure Red-Cell Aplasia 01/2022 - 08/2021
2	Carcinogenesis 10/2020 - 04/2014
2	Virus Diseases (Viral Diseases) 01/2020 - 12/2018
2	Ovarian Epithelial Carcinoma 12/2017 - 04/2014
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2015 - 01/2015
1	Primary Myelofibrosis (Myelosclerosis) 03/2024
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024
1	Viremia 03/2024
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024
1	COVID-19 03/2024
1	Hemorrhage 02/2024
1	Inflammation (Inflammations) 01/2023
1	Sepsis (Septicemia) 01/2022
1	Lymphoid Leukemia 01/2022
1	Myocarditis (Carditis) 01/2022
1	Poisoning 01/2021

Drug/Important Bio-Agent (IBA)

11	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2016
6	Imatinib Mesylate (Gleevec)FDA Link 02/2024 - 05/2009
6	ruxolitinibIBA 01/2022 - 01/2020
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2024 - 10/2019
3	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2014
3	CytokinesIBA 12/2023 - 03/2017
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2021 - 10/2011
3	SteroidsIBA 01/2021 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2013
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 10/2011
2	Cystatin BIBA 03/2024 - 04/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 02/2024 - 06/2014
2	Dasatinib (BMS 354825)FDA Link 02/2024 - 01/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2022
2	Prostaglandins FIBA 01/2022 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 04/2021
2	EnzymesIBA 01/2022 - 12/2017
2	eltrombopag FDA Link 08/2021 - 11/2020
2	GlobulinsIBA 01/2021 - 10/2014
2	Thomsen-Friedenreich antibodiesIBA 01/2021 - 10/2014
2	Therapeutic UsesIBA 10/2020 - 12/2018
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 04/2014
2	Etanercept (Enbrel)FDA Link 01/2020 - 01/2017
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 07/2013
2	Prednisone (Sone)FDA LinkGeneric 12/2019 - 07/2013
2	Ferritins (Ferritin)IBA 01/2019 - 04/2013
2	Asparaginase (Elspar)FDA Link 02/2015 - 01/2015
2	Bortezomib (Velcade)FDA Link 01/2014 - 12/2009
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2013 - 10/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2013 - 10/2011
1	thymoglobulin FDA Link 03/2024
1	amsonic acid (DAS)IBA 02/2024
1	Histone Deacetylase InhibitorsIBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 12/2023
1	Superoxide DismutaseIBA 12/2023
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 12/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2023
1	CorticosteroneIBA 12/2023
1	AntioxidantsIBA 12/2023
1	MelatoninIBA 12/2023
1	Malondialdehyde (Propanedial)IBA 12/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023
1	Methylprednisolone FDA LinkGeneric 01/2022
1	CalcineurinIBA 01/2022
1	venetoclaxIBA 01/2022
1	TroponinIBA 01/2022
1	Janus KinasesIBA 01/2021
1	blinatumomabIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	AcrylonitrileIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021

Therapy/Procedure

45	Hematopoietic Stem Cell Transplantation 03/2024 - 05/2011
19	Therapeutics 01/2023 - 05/2009
14	Transplantation 02/2024 - 04/2011
10	Drug Therapy (Chemotherapy) 01/2023 - 08/2011
7	Stem Cell Transplantation 02/2024 - 09/2013
5	Salvage Therapy 01/2023 - 06/2014
1	Aftercare (After-Treatment) 01/2023
1	Fecal Microbiota Transplantation 01/2023
1	Immunotherapy 01/2022
1	Donor Selection 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2022